Goodrx Holdings Inc
NASDAQ:GDRX

Watchlist Manager
Goodrx Holdings Inc Logo
Goodrx Holdings Inc
NASDAQ:GDRX
Watchlist
Price: 2.15 USD -0.92% Market Closed
Market Cap: $736.5m

Goodrx Holdings Inc
No Economic Moat

No Moat
Narrow
Wide
What is Economic Moat?

Goodrx Holdings Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Goodrx Holdings Inc
Competitive Advantages

View Wide Economic Moat Stocks

Wide Economic Moat Companies

Company Last Price Price Change Market Cap Economic Moat
NVIDIA Corp
NVDA
$178.56
+0.8%
$4.3T Wide
Apple Inc
AAPL
$248.8416
+2.1%
$3.7T Wide
Alphabet Inc
GOOGL
$307.13
-0.2%
$3.7T Wide
Microsoft Corp
MSFT
$389.02
+1%
$2.9T Wide
Amazon.com Inc
AMZN
$208.76
+1.6%
$2.2T Wide
Taiwan Semiconductor Manufacturing Co Ltd
2330
NT$1 850
+2.4%
$1.5T Wide
Meta Platforms Inc
META
$606.7
+0.1%
$1.5T Wide
Broadcom Inc
AVGO
$319.84
-1.8%
$1.5T Wide
Walmart Inc
WMT
$121.09
+0.6%
$965.1B Wide
Eli Lilly and Co
LLY
$917.5
-1.3%
$867.4B Wide
Load More
Company Last Price Price Change Market Cap Economic Moat
Royal Bank of Canada
RY
CA$220.25
-0.3%
$225.1B Wide
Toronto-Dominion Bank
TD
CA$128.64
-0.6%
$159.3B Wide
Canadian Pacific Railway Ltd
CP
CA$107.84
+1.4%
$70.7B Wide
Canadian National Railway Co
CNR
CA$136.12
+0.7%
$61.3B Wide
Corteva Inc
CTVA
$78.07
+1.5%
$52.8B Wide
W W Grainger Inc
GWW
$1 043.05
+0.6%
$49.6B Wide
AMETEK Inc
AME
$211.5
+1.8%
$48.7B Wide
Yum! Brands Inc
YUM
$156.25
-0.5%
$43.4B Wide
Waste Connections Inc
WCN
CA$226.3
+1.6%
$42.3B Wide
Thomson Reuters Corp
TRI
CA$128.2
+10.4%
$41.6B Wide
Load More

Goodrx Holdings Inc
Glance View

GoodRx Holdings Inc., established at the intersection of healthcare and technology, has carved a niche in the American pharmaceutical industry by addressing one of its most notorious challenges: the high cost of prescription medications. Originally founded in 2011, GoodRx aims to ease the financial burden of medication costs for consumers by providing a platform that aggregates drug pricing information from pharmacies across the United States. By doing so, it empowers users to compare prices, identify potential savings, and subsequently make informed decisions about their medication purchases. At its core, GoodRx operates as a digital intermediary; its app and website seamlessly connect consumers with discounted prescription offers through partnerships with pharmacy benefit managers (PBMs) and retail pharmacies. The company's revenue model is primarily built on a commission and advertising framework. When users select a coupon from GoodRx and purchase at a pharmacy, the company receives a fee from its pharmacy partners or PBMs. Additionally, GoodRx leverages its vast user base, which is largely driven by organic traffic resulting from the essential nature of its service, to generate advertising revenues from pharmaceutical companies and other health-related entities eager to reach consumers actively seeking medication solutions. By continually expanding its services, such as telehealth offerings and a subscription model called GoodRx Gold, the company seeks to deepen its integration into the consumer healthcare experience while maintaining its core mission of providing accessible and affordable medication options.

GDRX Intrinsic Value
7.91 USD
Undervaluation 73%
Intrinsic Value
Price
The Power of Economic Moat

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

The Power of
Economic Moat
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett